Skip to main content
Top
Published in: Surgical Endoscopy 6/2009

01-06-2009

Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling

Authors: Daniel S. Oh, Steven R. DeMeester, Christy M. Dunst, Ryutaro Mori, Bethany J. Lehman, Hidekazu Kuramochi, Kathleen Danenberg, Peter Danenberg, Jeffrey A. Hagen, Parakrama Chandrasoma, Tom R. DeMeester

Published in: Surgical Endoscopy | Issue 6/2009

Login to get access

Abstract

Background

A rodent model of gastroduodenal–esophageal reflux can result in replacement of squamous esophageal mucosa with intestinal-type columnar mucosa and carcinoma. The validity of this model is debated, as it is unproven whether this mucosa is intestinal metaplasia due to reflux or represents migration of adjacent jejunal mucosa above the anastomosis. The aim of this study was to evaluate the esophageal intestinal-type mucosa in these animals by measuring expression of trefoil factor genes (TFF-1, -2, -3) and comparing it with adjacent jejunum in order to determine its etiology.

Methods

Twenty-five rats underwent esophagojejunostomy at the ligament of Treitz to induce reflux of gastric and duodenal contents. The animals were sacrificed at 16 weeks (n = 14) and 30 weeks (n = 11). After sacrifice, the distal esophagus, jejunum, and colon were obtained. RNA was isolated, reverse transcribed, and messenger RNA (mRNA) expression of TFF-1, -2, and -3 was measured with real-time polymerase chain reaction (PCR). Linear discriminant analysis classified samples based on gene expression.

Results

Esophageal intestinal-type mucosa was present at sacrifice in 18 animals. Compared to jejunum, the expression of TFF-1 and TFF-2 mRNA in the intestinal mucosa of the distal esophagus was increased (p = 0.0007 and p < 0.0001, respectively). Expression of TFF-3 was also increased in esophageal intestinal mucosa compared with jejunum (p = 0.0002), but there was significant overlap in expression between these tissues for this gene. Linear discriminant analysis misclassified esophageal intestinal-type mucosa as jejunum in only one case. In no cases was jejunum misclassified as esophageal intestinal-type mucosa.

Conclusion

The gene expression profile of esophageal intestinal-type mucosa following surgically induced reflux in a rodent model indicates that this represents intestinal metaplasia, not proximal migration of jejunum. This validates this model for studying the pathogenesis of Barrett’s esophagus. Use of this model has potential for assessment of the impact of various therapies on the natural history of reflux disease.
Literature
1.
go back to reference Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(2):142–146PubMedCrossRef Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(2):142–146PubMedCrossRef
2.
go back to reference Kubo A, Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99(4):582–588PubMedCrossRef Kubo A, Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99(4):582–588PubMedCrossRef
3.
go back to reference van Blankenstein M, Looman CWN, Johnston BJ, Caygill CPJ (2005) Age and sex distribution of the prevalence of Barrett’s esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100(3):568–576PubMedCrossRef van Blankenstein M, Looman CWN, Johnston BJ, Caygill CPJ (2005) Age and sex distribution of the prevalence of Barrett’s esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100(3):568–576PubMedCrossRef
4.
go back to reference van Soest EM, Dieleman JP, Siersema PD et al (2005) Increasing incidence of Barrett’s oesophagus in the general population. Gut 54(8):1062–1066PubMedCrossRef van Soest EM, Dieleman JP, Siersema PD et al (2005) Increasing incidence of Barrett’s oesophagus in the general population. Gut 54(8):1062–1066PubMedCrossRef
5.
go back to reference Oberg S, Johansson J, Wenner J, Walther B (2002) Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235(3):338–345PubMedCrossRef Oberg S, Johansson J, Wenner J, Walther B (2002) Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235(3):338–345PubMedCrossRef
6.
go back to reference Theisen J, Nigro JJ, DeMeester TR et al (2004) Chronology of the Barrett’s metaplasia-dysplasia-carcinoma sequence. Dis Esophag 17(1):67–70CrossRef Theisen J, Nigro JJ, DeMeester TR et al (2004) Chronology of the Barrett’s metaplasia-dysplasia-carcinoma sequence. Dis Esophag 17(1):67–70CrossRef
7.
go back to reference Miwa K, Sahara H, Segawa M et al (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67(2):269–274PubMedCrossRef Miwa K, Sahara H, Segawa M et al (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67(2):269–274PubMedCrossRef
8.
go back to reference Attwood SE, Smyrk TC, DeMeester TR et al (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111(5):503–510PubMed Attwood SE, Smyrk TC, DeMeester TR et al (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111(5):503–510PubMed
9.
go back to reference Ireland AP, Peters JH, Smyrk TC et al (1996) Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 224(3):358–370, discussion 370–371PubMedCrossRef Ireland AP, Peters JH, Smyrk TC et al (1996) Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 224(3):358–370, discussion 370–371PubMedCrossRef
10.
go back to reference Fein M, Peters JH, Chandrasoma P et al (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2(3):260–268PubMedCrossRef Fein M, Peters JH, Chandrasoma P et al (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2(3):260–268PubMedCrossRef
11.
go back to reference Nishijima K, Miwa K, Miyashita T et al (2004) Impact of the biliary diversion procedure on carcinogenesis in Barrett’s esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240(1):57–67PubMedCrossRef Nishijima K, Miwa K, Miyashita T et al (2004) Impact of the biliary diversion procedure on carcinogenesis in Barrett’s esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240(1):57–67PubMedCrossRef
12.
go back to reference Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CB, DeMeester TR (1997) Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1:27–33PubMedCrossRef Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CB, DeMeester TR (1997) Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1:27–33PubMedCrossRef
13.
go back to reference Sato T, Miwa K, Sahara H et al (2002) The sequential model of Barrett’s esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res 22(1A):39–44PubMed Sato T, Miwa K, Sahara H et al (2002) The sequential model of Barrett’s esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res 22(1A):39–44PubMed
14.
go back to reference Goldstein SR, Yang GY, Curtis SK et al (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18(11):2265–2270PubMedCrossRef Goldstein SR, Yang GY, Curtis SK et al (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18(11):2265–2270PubMedCrossRef
15.
go back to reference Bonner RF, Emmert-Buck M, Cole K et al (1997) Laser capture microdissection: molecular analysis of tissue. Science 278(5342):1481,1483 Bonner RF, Emmert-Buck M, Cole K et al (1997) Laser capture microdissection: molecular analysis of tissue. Science 278(5342):1481,1483
16.
go back to reference Vallbohmer D, Peters JH, Oh D et al (2005) Survivin, a potential biomarker in the development of Barrett’s adenocarcinoma. Surgery 138(4):701–706, discussion 706–707PubMedCrossRef Vallbohmer D, Peters JH, Oh D et al (2005) Survivin, a potential biomarker in the development of Barrett’s adenocarcinoma. Surgery 138(4):701–706, discussion 706–707PubMedCrossRef
17.
go back to reference Levrat M, Lambert R, Kirshbaum G (1962) Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis 7(6):564–573PubMedCrossRef Levrat M, Lambert R, Kirshbaum G (1962) Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis 7(6):564–573PubMedCrossRef
18.
go back to reference Mirvish SS, Huang Q, Chen SC et al (1993) Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 25(9):627–631PubMedCrossRef Mirvish SS, Huang Q, Chen SC et al (1993) Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 25(9):627–631PubMedCrossRef
19.
go back to reference Clark GW, Smyrk TC, Mirvish SS et al (1994) Effect of gastroduodenal juice and dietary fat on the development of Barrett’s esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1(3):252–261PubMedCrossRef Clark GW, Smyrk TC, Mirvish SS et al (1994) Effect of gastroduodenal juice and dietary fat on the development of Barrett’s esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1(3):252–261PubMedCrossRef
20.
go back to reference Oberg S, Lord RV, Peters JH et al (2000) Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? J Surg Res 91(2):111–117PubMedCrossRef Oberg S, Lord RV, Peters JH et al (2000) Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? J Surg Res 91(2):111–117PubMedCrossRef
21.
go back to reference Pera M, Pera M (2002) Experimental Barrett’s esophagus and the origin of intestinal metaplasia. Chest Surg Clin North Am 12(1):25–37CrossRef Pera M, Pera M (2002) Experimental Barrett’s esophagus and the origin of intestinal metaplasia. Chest Surg Clin North Am 12(1):25–37CrossRef
22.
go back to reference Kumagai H, Mukaisho K, Sugihara H et al (2003) Cell kinetic study on histogenesis of Barrett’s esophagus using rat reflux model. Scand J Gastroenterol 38(7):687–692PubMedCrossRef Kumagai H, Mukaisho K, Sugihara H et al (2003) Cell kinetic study on histogenesis of Barrett’s esophagus using rat reflux model. Scand J Gastroenterol 38(7):687–692PubMedCrossRef
23.
go back to reference Buskens CJ, Hulscher JBF, van Gulik TM et al (2006) Histopathologic evaluation of an animal model for Barrett’s esophagus and adenocarcinoma of the distal esophagus. J Surg Res 135(2):337–344PubMedCrossRef Buskens CJ, Hulscher JBF, van Gulik TM et al (2006) Histopathologic evaluation of an animal model for Barrett’s esophagus and adenocarcinoma of the distal esophagus. J Surg Res 135(2):337–344PubMedCrossRef
24.
go back to reference Warson C, Van De Bovenkamp JHB, Korteland-Van Male AM et al (2002) Barrett’s esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Human Pathol 33(6):660–668CrossRef Warson C, Van De Bovenkamp JHB, Korteland-Van Male AM et al (2002) Barrett’s esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Human Pathol 33(6):660–668CrossRef
25.
go back to reference DeMeester SR, DeMeester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 231(3):303–321PubMedCrossRef DeMeester SR, DeMeester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 231(3):303–321PubMedCrossRef
26.
go back to reference Oh DS, Hagen JA, Fein M et al (2006) Impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 10(6):787–797PubMedCrossRef Oh DS, Hagen JA, Fein M et al (2006) Impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 10(6):787–797PubMedCrossRef
27.
go back to reference Campos GM, DeMeester SR, Peters JH et al (2001) Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 136(11):1267–1273PubMedCrossRef Campos GM, DeMeester SR, Peters JH et al (2001) Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 136(11):1267–1273PubMedCrossRef
28.
go back to reference Barley NF, Taylor V, Shaw-Smith CJ et al (2003) Human ileal bile acid-binding protein promoter and the effects of CDX2. Biochim Biophys Acta 1630(2–3):138–143PubMed Barley NF, Taylor V, Shaw-Smith CJ et al (2003) Human ileal bile acid-binding protein promoter and the effects of CDX2. Biochim Biophys Acta 1630(2–3):138–143PubMed
29.
go back to reference Kazumori H, Ishihara S, Rumi MAK et al (2006) Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium. Gut 55(1):16–25PubMedCrossRef Kazumori H, Ishihara S, Rumi MAK et al (2006) Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett’s epithelium. Gut 55(1):16–25PubMedCrossRef
30.
go back to reference Hu Y, Williams VA, Gellersen O et al (2007) The pathogenesis of Barrett’s esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells. J Gastrointest Surg 11(7):827–834PubMedCrossRef Hu Y, Williams VA, Gellersen O et al (2007) The pathogenesis of Barrett’s esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells. J Gastrointest Surg 11(7):827–834PubMedCrossRef
31.
go back to reference Hu Y, Jones C, Gellersen O et al (2007) Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg 142(6):540–544, discussion 544–545PubMedCrossRef Hu Y, Jones C, Gellersen O et al (2007) Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg 142(6):540–544, discussion 544–545PubMedCrossRef
32.
go back to reference Shimada H, Koike T, Yamagata M, Yoneda M, Hiraishi H (2007) Regulation of TFF3 expression by homeodomain protein CDX2. Regulat Peptides 140:81–87CrossRef Shimada H, Koike T, Yamagata M, Yoneda M, Hiraishi H (2007) Regulation of TFF3 expression by homeodomain protein CDX2. Regulat Peptides 140:81–87CrossRef
33.
go back to reference Baus-Loncar M, Giraud AS (2005) Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Molec Life Sci 62(24):2921–2931PubMedCrossRef Baus-Loncar M, Giraud AS (2005) Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Molec Life Sci 62(24):2921–2931PubMedCrossRef
34.
go back to reference Emami S, Rodrigues S, Rodrigue CM et al (2004) Trefoil factor family (TFF) peptides and cancer progression. Peptides 25(5):885–898PubMedCrossRef Emami S, Rodrigues S, Rodrigue CM et al (2004) Trefoil factor family (TFF) peptides and cancer progression. Peptides 25(5):885–898PubMedCrossRef
Metadata
Title
Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling
Authors
Daniel S. Oh
Steven R. DeMeester
Christy M. Dunst
Ryutaro Mori
Bethany J. Lehman
Hidekazu Kuramochi
Kathleen Danenberg
Peter Danenberg
Jeffrey A. Hagen
Parakrama Chandrasoma
Tom R. DeMeester
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 6/2009
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-008-0169-5

Other articles of this Issue 6/2009

Surgical Endoscopy 6/2009 Go to the issue